✦ LIBER ✦

O-25 A feasibility study of active symptom control (ASC) with or without chemotherapy in malignant pleural mesothelioma

✍ Scribed by Muers, Martin F.; Rudd, Robin; Hodson, Adrian; Owen, Robert; Qian, Wendi; Stephens, Richard J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Active symptom control with or without c

✍ Martin F Muers; Richard J Stephens; Patricia Fisher; Liz Darlison; Christopher M 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 231 KB

4BA Active symptom control (ASC) with or

✍ M. Muers; P. Fisher; M. O'Brien; M. Peake; R. Rudd; M. Snee; J. Steele; M. Nanki 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Pleural space perfusion with cisplatin i

✍ Giovanni B. Ratto; Dario Civalleri; Mauro Esposito; Elisabetta Spessa; Antonella 📂 Article 📅 1999 🏛 CTSNet 🌐 English ⚖ 69 KB

Malignant Pleural Mesothelioma Patients’

✍ Shah, A.; Culligan, M.; Friedberg, J.S.; Sterman, D.H.; Alley, E.; Stevenson, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Locoregional Control and Toxicity After

✍ Blake, M.; Macedo, O.; Corona, F.; Bacon-Fonseca, L.; Mendez, G.; Sanchez, R.; A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 74 KB

P-410 Prognostic factor analysis of EORT

✍ Legrand, C.; Gafaar, R.; Manegold, C.; van Klaveren, R.; Vincent, M.; Passioukov 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB